Healthy, mtDNA-mutation free mesoangioblasts from mtDNA patients qualify for autologous therapy

BACKGROUND: Myopathy and exercise intolerance are prominent clinical features in carriers of a point-mutation or large-scale deletion in the mitochondrial DNA (mtDNA). In the majority of patients, the mtDNA mutation is heteroplasmic with varying mutation loads between tissues of an individual. Exerc...

Descripción completa

Detalles Bibliográficos
Autores principales: van Tienen, Florence, Zelissen, Ruby, Timmer, Erika, van Gisbergen, Marike, Lindsey, Patrick, Quattrocelli, Mattia, Sampaolesi, Maurilio, Mulder-den Hartog, Elvira, de Coo, Irenaeus, Smeets, Hubert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925445/
https://www.ncbi.nlm.nih.gov/pubmed/31864395
http://dx.doi.org/10.1186/s13287-019-1510-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925445/
https://www.ncbi.nlm.nih.gov/pubmed/31864395
http://dx.doi.org/10.1186/s13287-019-1510-8

Ejemplares similares